Recro Pharma, Inc. (REPH): Price and Financial Metrics
REPH Price/Volume Stats
| Current price | $2.09 | 52-week high | $3.79 |
| Prev. close | $2.10 | 52-week low | $1.38 |
| Day low | $2.00 | Volume | 141,800 |
| Day high | $2.14 | Avg. volume | 126,298 |
| 50-day MA | $1.71 | Dividend yield | N/A |
| 200-day MA | $1.89 | Market Cap | 117.93M |
REPH Stock Price Chart Interactive Chart >
Recro Pharma, Inc. (REPH) Company Bio
Recro Pharma is a clinical stage specialty pharmaceutical company, engaging in developing non-opioid therapeutics for the treatment of pain. The company was founded in 2007 and is based in Malvern, Pennsylvania.
REPH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 38.41% |
| 5-year | -88.38% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -40.00% |
| 2020 | -84.45% |
| 2019 | 158.17% |
Continue Researching REPH
Want to see what other sources are saying about Recro Pharma Inc's financials and stock price? Try the links below:Recro Pharma Inc (REPH) Stock Price | Nasdaq
Recro Pharma Inc (REPH) Stock Quote, History and News - Yahoo Finance
Recro Pharma Inc (REPH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...